Plus Therapeutics Inc
NASDAQ:PSTV 4:00:00 PM EDT
| Market Cap (Intraday) | 6.84M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.70 |
| 50-Day MA | $1.84 |
| 200-Day MA | $1.88 |
Plus Therapeutics Inc Stock, NASDAQ:PSTV
4200 Marathon Boulevard, Suite 200, Austin, Texas 78756
United States of America
Phone: +1.210.974.6900
Number of Employees: 20
Description
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX.